Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human SLC22A8 Stable Cell Line

    [CAT#: S01YF-1123-KX127]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    Transporter Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Based on this stable cell line, we also provide cell-based in vitro assays to evaluate the effects of your compounds or antibodies.

    Sub Cat Product Name Target Protein Species Host Cell Type Assay Types Inquiry Datasheet
    S01YF-0922-KX1566 Magic™ Human SLC22A8 in Vitro Drug screening assay Human Caco-2, MDCK, HEK293, CHO, membrane vesicles, and various transfected cells lines Activity Assay (High throughput screening assays; Large scale single dose, duplicate profiling; IC50 profiling; Ki determination assay; Substrate determination assay )

    Product Information

    Target Protein
    SLC22A8
    Target Family
    SLC Transporter
    Target Protein Species
    Human
    Host Cell Type
    CHO-K1; HEK293
    Target Classification
    Transporter Cell Lines
    Target Research Area
    Digestive and Renal Research; Metabolic Research
    Related Diseases
    Gout; Hyperuricemia
    Gene ID
    UniProt ID

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    The human SLC22A8 gene encodes the protein known as organic anion transporter 3 (OAT3). Organic ions, some of which are pharmaceuticals and some of which are pure toxicants, are transported and excreted via OAT3. The inward sodium gradient, which propels dicarboxylate reentry into the cytosol, indirectly supports SLC22A8 (OAT3). To drive the influx of organic anions against their concentration gradient, dicarboxylates-such as alpha-ketoglutarate-are utilized as exchange substrates within cells or recycled from the external environment. The encoded protein is an integral membrane protein that is thought to be located on the renal proximal tubule cells' basolateral membrane. The customized SLC22A8 stable cell line can be used in antibody discovery and development, potential drug candidate screening and signaling pathway researches.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    chat Matthew

    The SLC22A8 cell line is approximately lower than other brands of reagents and I got similar results. Apr 27 2023

    chat Verified Customer

    chat Kevin

    The SLC22A8 cell line was easy to use, and the customer service team was responsive and helpful. Highly recommended! Dec 17 2022

    chat Verified Customer

    FAQ

    Any questions about our products? Please visit our frequently asked questions page.

    Published Data

    Fig.1 Expression of SLC22A8 (OAT3) and it´s allelic variants in HEK293T cells line.

    Elevated magnification of allelic variant R149C: HEK293T cells line expresses SLC22A8 (OAT3) and its allelic variations. Using polyethyleneimine lipofection, cells were transiently transfected with wild type protein that had been tagged with a C-terminal GFP tag.

    Ref: Vávra, Jiří, et al. "Functional Characterization of Rare Variants in OAT1/SLC22A6 and OAT3/SLC22A8 Urate Transporters Identified in a Gout and Hyperuricemia Cohort." Cells 11.7 (2022): 1063.

    Pubmed: 35406626

    DOI: 10.3390/cells11071063

    Research Highlights

    The idea that OAT1 is more significant in kidney proximal tubule metabolism and OAT3 is more significant in systemic metabolism-regulating the amounts of metabolites passing through the colon, liver, and kidney-is supported by metabolomics and pathway analysis.
    Bush, Kevin T., et al. "The drug transporter OAT3 (SLC22A8) and endogenous metabolite communication via the gut-liver-kidney axis." Journal of Biological Chemistry 292.38 (2017): 15789-15803.
    Pubmed: 28765282   DOI: 10.1074/jbc.M117.796516

    A thorough examination of the tumor microenvironment and tumor immune infiltration revealed a greater degree of general immunity in the SLC22A8 low expression group. The results of the Gene Enrichment Analysis demonstrated a correlation between low expression of SLC22A8 and immunological pathways, including humoral immune response and phagocytosis recognition. SLC22A8 expression can be employed as a predictive biomarker for ccRCC because it was found to be highly linked with both immune infiltration and survival in ccRCC.
    Xu, Ke, et al. "SLC22A8: An indicator for tumor immune microenvironment and prognosis of ccRCC from a comprehensive analysis of bioinformatics." Medicine 101.37 (2022).
    Pubmed: 36123895   DOI: 10.1097/MD.0000000000030270

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare